Venus Medtech (Hangzhou), Inc. Class H (HK:2500) has released an update.
Venus Medtech (Hangzhou) Inc. has successfully passed all resolutions during their 2023 Annual General Meeting (AGM), with attendance constituting 20.89% of total share capital. The resolutions included approval of the 2023 annual report, work reports of the board and supervisory committee, the profit distribution plan for 2023, and the re-appointment of auditors for 2024. Shareholders voted overwhelmingly in favor, with 99.933235% for and no votes against the resolutions.
For further insights into HK:2500 stock, check out TipRanks’ Stock Analysis page.
